Intravenous Glutamine Enhances COX-2 Activity Giving Cardioprotection

Journal of Surgical Research

Volumn 152, Issue 1, 2009, Pages 140-147

  McGuinness, Jonathan ^a   Neilan, Tom G ^b   Cummins, Rob ^a   Sharkasi, Adel ^c   Bouchier Hayes, David ^a   Redmond, J Mark ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^c UNIVERSITY OF BENGHAZI   (Libyan Arab Jamahiriya)

Author keywords

COX 2; glutamine; myocardial ischemia reperfusion; preconditioning; surgery

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CYCLOOXYGENASE 2; GLUTAMINE; HEAT SHOCK PROTEIN 72; MALONALDEHYDE; NITRATE; SODIUM CHLORIDE;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; CONTROL GROUP; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FUNCTIONAL ASSESSMENT; HEART; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; RABBIT; TISSUE LEVEL; UPREGULATION;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; CYCLOOXYGENASE 2; GLUTAMINE; HEMODYNAMICS; HSP72 HEAT-SHOCK PROTEINS; INJECTIONS, INTRAVENOUS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MALONDIALDEHYDE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRATES; RABBITS;

EID: 63049117667     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.03.045     Document Type: Article

References (25)

1. Bolli R. The late phase of preconditioning. Circ Res 87 (2000) 972
2. Bolli R., Becker L., Gross G., et al. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res 95 (2004) 125
3. Wang Y., Kodani E., Wang J., et al. Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2. Circ Res 95 (2004) 84
4. Shinmura K., Tang X.L., Wang Y., et al. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA 97 (2000) 10197
5. Shinmura K., Nagai M., Tamaki K., et al. COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts. Am J Physiol Heart Circ Physiol 283 (2002) H2534
6. Tanaka K., Ludwig L.M., Krolikowski J.G., et al. Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: Role of cyclooxygenase-2. Anesthesiology 100 (2004) 525
7. Wischmeyer P.E., Vanden Hoek T.L., Li C., et al. Glutamine preserves cardiomyocyte viability and enhances recovery of contractile function after ischemia-reperfusion injury. JPEN J Parenter Enteral Nutr 27 (2003) 116
8. Hayashi Y., Sawa Y., Fukuyama N., et al. Preoperative glutamine administration induces heat-shock protein 70 expression and attenuates cardiopulmonary bypass-induced inflammatory response by regulating nitric oxide synthase activity. Circulation 106 (2002) 2601
9. Ytrehus K., Liu Y., Tsuchida A., et al. Rat and rabbit heart infarction: Effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol 267 (1994) H2383
10. Robinson B.S., Hii C.S., Poulos A., et al. Effect of tumor necrosis factor-alpha on the metabolism of arachidonic acid in human neutrophils. J Lipid Res 37 (1996) 1234
11. Kodani E., Xuan Y.T., Shinmura K., et al. Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits. Am J Physiol Heart Circ Physiol 283 (2002) H1943
12. Wittstein I.S., Thiemann D.R., Lima J.A., et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 352 (2005) 539
13. Cohen M.V., Yang X.M., and Downey J.M. Smaller infarct after preconditioning does not predict extent of early functional improvement of reperfused heart. Am J Physiol 277 (1999) H1754
14. Khogali S.E., Pringle S.D., Weryk B.V., et al. Is glutamine beneficial in ischemic heart disease?. Nutrition 18 (2002) 123
15. van der Hulst R.R., van Kreel B.K., von Meyenfeldt M.F., et al. Glutamine and the preservation of gut integrity. Lancet 341 (1993) 1363
16. Wischmeyer P.E., Kahana M., Wolfson R., et al. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock 16 (2001) 398
17. Wischmeyer P.E. Glutamine and heat shock protein expression. Nutrition 18 (2002) 225-228
18. Benjamin I.J., and McMillan D.R. Stress (heat shock) proteins: Molecular chaperones in cardiovascular biology and disease. Circ Res 83 (1998) 117
19. Wischmeyer P.E., Kahana M., Wolfson R., et al. Glutamine induces heat shock protein and protects against endotoxin shock in the rat. J Appl Physiol 90 (2001) 2403
20. Ehrenfried J.A., Chen J., Li J., et al. Glutamine-mediated regulation of heat shock protein expression in intestinal cells. Surgery 118 (1995) 352 ; discussion 356.
21. Alcindor D., Krolikowski J.G., Pagel P.S., et al. Cyclooxygenase-2 mediates ischemic, anesthetic, and pharmacologic preconditioning in vivo. Anesthesiology 100 (2004) 547
22. Rossoni G., Muscara M.N., Cirino G., et al. Inhibition of cyclo-oxygenase-2 exacerbates ischaemia-induced acute myocardial dysfunction in the rabbit. Br J Pharmacol 135 (2002) 1540
23. Thiemermann C., and Zacharowski K. Selective activation of E-type prostanoid(3)-receptors reduces myocardial infarct size. A novel insight into the cardioprotective effects of prostaglandins. Pharmacol Ther 87 (2000) 61
24. Shinmura K., Tamaki K., Sato T., et al. Prostacyclin attenuates oxidative damage of myocytes by opening mitochondrial ATP-sensitive K+ channels via the EP3 receptor. Am J Physiol Heart Circ Physiol 288 (2005) H2093
25. Garlick P.J. Assessment of the safety of glutamine and other amino acids. J Nutr 131 (2001) 2556S